Substudy - Evaluation of Patients With Iliac Vein Thrombosis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

85 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-11-30

Study Completion Date

2018-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients with previous diagnosis of iliac vein thrombosis are enrolled in this registry. Using standardized questionnaire, clinical data detailing venous thromboembolism and contributing VTE risk factors are recorded. Results of technical and laboratory investigations including screening of thrombophilic disorders were additionally entered into the database.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Frankfurt Thrombophilia Registry

NCT00683397

Venous Thromboembolism

COMPLETED

Acute and Subacute Iliofemoral and/or Caval Deep Vein Thrombosis: Evaluation of Mechanical Thrombectomy Systems

NCT06288906

Thrombosis, Venous

RECRUITING

Epidemiology of Thromboembolism Disease: A Cohort Study

NCT00670540

Vascular Diseases Embolism and Thrombosis Phlebitis +2 more

COMPLETED

Global Anticoagulant Registry in the FIELD- Venous Thromboembolic Events

NCT02155491

Venous Thromboembolism Deep Vein Thrombosis Pulmonary Embolism

COMPLETED

Risk Factors for Venous Thromboembolism in the Community

NCT00011180

Cardiovascular Diseases Thromboembolism

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Iliac Vein Thrombosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with iliofermoral thrombosis without rekanalisation

subjects with proven iliofemoral thrombosis (V. cava-aplasia, pelvic vein thrombosis, VTE) which was proven by objective methods such as Duplex sonography, CT/MRT, phlebography and who did not undergo recanalisation

thrombophilia screening

Intervention Type GENETIC

genetic Evaluation of Factor-V-Leiden, Factor-II\_G20210A Mutation;

Patients with ilifermoral thrombosis with rekanalisation

subjects with proven iliofemoral thrombosis (V. cava-aplasia, pelvic vein thrombosis, VTE) which was proven by objective methods such as Duplex sonography, CT/MRT, phlebography and who did undergo recanalisation

thrombophilia screening

Intervention Type GENETIC

genetic Evaluation of Factor-V-Leiden, Factor-II\_G20210A Mutation;

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

thrombophilia screening

genetic Evaluation of Factor-V-Leiden, Factor-II\_G20210A Mutation;

Intervention Type GENETIC

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* \>18 years
* subjects with iliofermoral thrombosis, which has been proven by objective measurements (Duplex sonography, phlebography, CT/MRT) later than 1996